Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line
Zainab Lafi(Al-Ahliyya Amman University), Abed Alqader Ibrahim(University of North Carolina at Greensboro), Lobna Gharaibeh(Al-Ahliyya Amman University), Banan Bashaireh(University of Jordan), Baidaa AlQuaissi(University of Jordan), Dana A. Alqudah(University of Jordan), Walhan Alshaer(University of Jordan)
Cited by 22
Related Papers
Liposome bilayer stability: emphasis on cholesterol and its alternatives
|Journal of Liposome Research|2023|88
Cellulose Acetate Membranes: Fouling Types and Antifouling Strategies—A Brief Review
|Processes|2023|49
How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery? A Comprehensive Review of the Literature
|International Journal of Nanomedicine|2025|30
Fabrication of a Novel (PVDF/MWCNT/Polypyrrole) Antifouling High Flux Ultrafiltration Membrane for Crude Oil Wastewater Treatment
|Membranes|2022|25
Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation
|Expert Opinion on Drug Delivery|2024|21